Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Mottet N, Cornford P, van den Bergh RCN, Briers E, De Santis M, Fanti S, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. European Association of Urology; https://uroweb.org/guideline/prostate-cancer/. Accessed 20 Apr 2020.
2. Corona G, Gacci M, Baldi E, Mancina R, Forti G, Maggi M. Androgen deprivation therapy in prostate cancer: focusing on sexual side effects. J Sex Med. 2012;9:887–902.
3. Corona G, Baldi E, Maggi M. Androgen regulation of prostate cancer: where are we now? J Endocrinol Investig. 2011;34:232–43.
4. Corona G, Filippi S, Bianchi N, Dicuio M, Rastrelli G, Concetti S, et al. Cardiovascular risks of androgen deprivation therapy for prostate cancer. World J Men’s Health. 2020. https://doi.org/10.5534/wjmh.200109.
5. Levine GN, D’Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. 2010;121:833–40.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献